These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8421025)

  • 41. Neurological features in Gaucher's disease during enzyme replacement therapy.
    Ono H; Fujiwara M; Ito K; Ueda H; Mizoguchi N; Sakura N
    Acta Paediatr; 2001 Feb; 90(2):229-31. PubMed ID: 11236058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gaucher's disease. Enzyme therapy is not enough.
    Grabowski GA
    Lancet; 2001 Dec; 358 Suppl():S29. PubMed ID: 11784578
    [No Abstract]   [Full Text] [Related]  

  • 43. [Gaucher's disease and enzyme replacement therapy].
    Cornu F
    Ann Pharm Fr; 1998; 56(3):102-7. PubMed ID: 9770016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of Gaucher's disease.
    Sidransky E; Martin B; Ginns EI
    N Engl J Med; 1993 May; 328(21):1566; author reply 1567. PubMed ID: 8479500
    [No Abstract]   [Full Text] [Related]  

  • 45. Eliglustat for Gaucher's disease: trippingly on the tongue.
    Hughes DA; Pastores GM
    Lancet; 2015 Jun; 385(9985):2328-30. PubMed ID: 25819692
    [No Abstract]   [Full Text] [Related]  

  • 46. [Enzyme substitution in Gauscher disease].
    Steensberg J; Nielsen KG; Brandt NJ
    Ugeskr Laeger; 1998 Jun; 160(26):3900-3. PubMed ID: 9656829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enzyme replacement therapy in the management of longstanding skeletal and soft tissue salmonella infection in a patient with Gaucher's disease.
    Margalit M; Ash N; Zimran A; Halkin H
    Postgrad Med J; 2002 Sep; 78(923):564-5. PubMed ID: 12357022
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone crisis in stable Gaucher's disease.
    Pérez-Calvo JI; Roca-Espiaú M; Pastores GM
    QJM; 2005 Dec; 98(12):916-8. PubMed ID: 16299062
    [No Abstract]   [Full Text] [Related]  

  • 49. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
    Mazher W; Ali J; Abubakar S; Basar S; Murtaza G
    J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Osteoarticular manifestations of Gaucher's Disease and imiglucerase efficacy on bone mineral density in adults. Review of literature].
    Schaeverbeke T
    Presse Med; 2009 Dec; 38 Suppl 2():2S38-41. PubMed ID: 20304304
    [No Abstract]   [Full Text] [Related]  

  • 51. In brief: Velaglucerase (Vpriv) for Gaucher's disease.
    Med Lett Drugs Ther; 2010 May; 52(1337):36. PubMed ID: 20431522
    [No Abstract]   [Full Text] [Related]  

  • 52. Taliglucerase alfa for the treatment of Gaucher's disease.
    Haddley K
    Drugs Today (Barc); 2012 Aug; 48(8):525-32. PubMed ID: 22916340
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pregnancy after avascular necrosis of the femur complicating Gaucher's disease.
    Cleary JE; Burke WM; Baxi LV
    Am J Obstet Gynecol; 2001 Jan; 184(2):233-4. PubMed ID: 11174510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The health-related quality of life of adults with Gaucher's disease receiving enzyme replacement therapy: results from a retrospective study.
    Damiano AM; Pastores GM; Ware JE
    Qual Life Res; 1998 Jul; 7(5):373-86. PubMed ID: 9691718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gaucher's disease in Lithuania: its diagnosis and treatment.
    Kleinotienė G; Tylki-Szymanska A; Czartoryska B
    Medicina (Kaunas); 2011; 47(7):405-11. PubMed ID: 22112991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Managing public payment for high-cost, high-benefit treatment: enzyme replacement therapy for Gaucher's disease in Ontario.
    Clarke JT; Amato D; Deber RB
    CMAJ; 2001 Sep; 165(5):595-6. PubMed ID: 11563212
    [No Abstract]   [Full Text] [Related]  

  • 57. Alglucerase. A review of its therapeutic use in Gaucher's disease.
    Whittington R; Goa KL
    Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteonecrosis in a patient with Gaucher's disease treated with enzyme replacement.
    Lebel E; Elstein D; Hain D; Hadas-Halpern I; Zimran A; Itzchaki M
    Isr Med Assoc J; 2003 Aug; 5(8):595-6. PubMed ID: 12929302
    [No Abstract]   [Full Text] [Related]  

  • 59. Enzyme replacement and gene therapy for Gaucher's disease.
    Brady RO; Barton NW
    Lipids; 1996 Mar; 31 Suppl():S137-9. PubMed ID: 8729108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gaucher's disease.
    Elstein D; Abrahamov A; Hadas-Halpern I; Zimran A
    Lancet; 2001 Jul; 358(9278):324-7. PubMed ID: 11498237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.